Share

    


In This Section

Home / Immunotherapy

Immunotherapy

Today, with more than 40 cancer immunotherapy indications and over 2,000 clinical trials with cancer immunotherapies, the challenges and issues around patient selection, patient access and side effect management for the community cancer team have grown even more complex. ACCC recognizes and understands these complexities and the rapidly changing IO landscape and strives leading the exchange of solutions to proactively address the operational, optimization, research and educational challenges associated with cancer immunotherapies for the community cancer care team.

ACCC Immuno-Oncology Institute

The Association of Community Cancer Centers Immuno-Oncology Institute is the leader in optimizing the delivery of cancer immunotherapies for patients by providing clinical education, advocacy, research, and practice management solutions for cancer care teams across all healthcare settings.

Since 2015, ACCC has led the only initiative to prepare all members of the multidisciplinary cancer care for the complex implementation of immuno-oncology in the community setting.

View Immunotherapy Resources
Toxicity Team Article

Care Coordination & Immune-Related Adverse Events: Building a Multispecialty Immuno-Oncology Checkpoint Inhibitors Toxicity TeamDownload Article & Companion Guide

DownloadImmuno-Oncology: Transforming the Delivery of Cancer Care in the Community
Download Publication

 

Featured Programs

Elevating Survivorship

ACCC has partnered with the National Coalition for Cancer Survivorship (NCCS) on the Elevating Survivorship project. ACCC has launched a web-based survey to learn about gaps in survivorship care delivery, technical support needed to improve survivorship care, and unmet and evolving survivorship care needs of patients who have been treated with immunotherapy.
Learn More & Take Survey

Best Practices for Implementing IO in the Community

“Best Practices for Implementing Cancer Immunotherapy in the Community” is a new ACCC education opportunity that offers two ACCC-member programs customized learning for their multidisciplinary teams delivering immunotherapy for cancer, including an on-site training.
Learn More

Two ACCC member programs are participating in "Overcoming Obstacles in Integrating Immunotherapies for Cancer in the Community Setting," a quality improvement research study. Learn more and view the study design.
Learn More

Real-World Experience in Immunotherapy Delivery

Peer-to-peer learning focused on practical “how to’s” for integrating immunotherapy into practice in the community setting with a focus on physical space considerations, workflow, staffing, patient education, and lessons learned.
Learn More

Managing Immune-Related Adverse Events

The rapid pace of new approvals and indications in immunotherapy for cancer requires ongoing education to understand the spectrum of immune-related adverse events (irAEs) and how to effectively manage your patients’ irAEs using a multidisciplinary approach.
Learn More

From the ACCCBuzz Blog

Immunotherapy In the News

News Coverage


ACCC Immuno-Oncology Institute Executive Committee member Ivo Abraham, PhD, RN, comments on how we can demonstrate the value of cancer treatments.

Featured Webinar

Immuno-Oncology: Breaking Barriers, Exploring Solutions, Improving Patient Care

Dr. Una Hopkins ScreenshotWatch Now

On-Demand Webinars

From Oncology Issues

  • Elevating Survivorship: Results from Two National Surveys
    In order to explore experiences and needs concerning cancer survivorship from both the provider and the patient perspectives, ACCC and NCCS partnered to field two online surveys to oncology providers and cancer survivors, respectively.
  • A Physician Champion Takes a Practice-Based Immunotherapy Program to the Next Level
    Tracy Virgilio, RN, MSN, OCN
    Early symptom management is key to improving quality of life for patients with cancer, and proactive monitoring delivers unparalleled survival advantage while decreasing emergency visits and admissions. However, immunotherapies require special attention and procedures. Sidney Kimmel Cancer Center earned a 2018 ACCC Innovator Award for their immunotherapy triage algorithms, which provide non-oncology physicians and nurses with the tools to manage IO patients and prevent unnecessary admissions.
  •  Immuno-Oncology: Breaking Barriers, Exploring Solutions, Improving Patient Care
    The ACCC Immuno-Oncology Institute developed a multidisciplinary curriculum workshop bringing together faculty experienced in delivery of immunotherapy with cancer program staff in the earlier stages of IO integration. Over the past two years, these IO Visiting Experts Programs were hosted by ACCC Cancer Program Members nation-wide.
  •  Best Practices for Implementing Cancer Immunotherapy in the Community
    The Association of Community Cancer Centers (ACCC) recently hosted live continuing medical education (CME)-certified learning workshops at two community cancer programs to review current barriers to immunotherapy implementation in the community setting. During the workshops, an expert faculty panel engaged participants in discussion on the challenges that they may face as they integrate immunotherapy into their clinical practice, as well as practical solutions and strategies they can apply to overcome these barriers. This article summarizes the guidance and information provided by the faculty on the various issues raised during the workshop discussions.
  •  Highlights from ASCO 2018
    By Cary A. Presant, MD, FACP, FASCO
    ASCO 2018 offered a wealth of new data that will continue to transform clinical practice and cancer program development. Most important, implementation of the scientifi c advances we learned at ASCO 2018 will improve the length and quality of life of our cancer patients.
  •  Turning on the Light Switch
    By Ann McGreal, RN
    Discover how 2017 ACCC Innovator Award winner Advocate Medical Group developed and implemented an immunotherapy program, lessons learned, and tools created to educate staff and patients.
  •  Best of ASCO 2017
    Cary A. Presant, MD, FACP, FASCO
    ASCO 2017 was filled with new information and long lines as 39,000 oncologists worldwide came together to hear the latest advances in cancer care.
  •  Real-World Experiences in Immunotherapy Delivery
    The ACCC education project, “Real-World Experiences in Immunotherapy Delivery,” addresses some of the practical issues that cancer programs must navigate to provide immunotherapy safely and effectively in their own communities.
  •  Advancing Immuno-Oncology in the Community Setting
    Steven Powell, MD
    As cancer treatment evolves with the emergence of genomics, personalized therapies, and immunotherapies, care delivery must also transform.

ADVERTISEMENT

SITC - Advances in Cancer Immunotherapy